1-(carboxymethylthio)tetradecane has been researched along with Leukemia, Promyelocytic, Acute in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berge, K; Berge, RK; Brustugun, OT; Døskeland, SO; Gjertsen, BT; Krakstad, C; Tronstad, KJ | 1 |
Berge, RK; Drevon, CA; Gudbrandsen, OA; Iversen, PO; Rustan, AC; Sørensen, DR; Tronstad, KJ | 1 |
2 other study(ies) available for 1-(carboxymethylthio)tetradecane and Leukemia, Promyelocytic, Acute
Article | Year |
---|---|
Mitochondrial-targeted fatty acid analog induces apoptosis with selective loss of mitochondrial glutathione in promyelocytic leukemia cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspases; Cell Line, Tumor; Cell Nucleus; Cyclic AMP; Cytochromes c; Cytosol; Fluorescent Dyes; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Glutathione; Image Processing, Computer-Assisted; Immunoassay; Leukemia, Promyelocytic, Acute; Mice; Mitochondria; Subcellular Fractions; Sulfides; Thionucleotides | 2003 |
A bioactively modified fatty acid improves survival and impairs metastasis in preclinical models of acute leukemia.
Topics: Animals; Apoptosis; Diet; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Activation; Fatty Acids, Unsaturated; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Promyelocytic, Acute; Leukemic Infiltration; Matrix Metalloproteinases; Neoplasm Metastasis; Rats; Structure-Activity Relationship; Sulfides; Survival Rate; Transplantation, Heterologous; Xenograft Model Antitumor Assays | 2006 |